Request for Covid-19 Impact Assessment of this Report

Healthcare

Orthopedic Implants Market by Product [Reconstructive Joint Replacements {Knee Replacement Implants, Hip Replacement Implants, and Extremities}, Spinal Implants {Spinal Fusion Devices, Non-Fusion Devices/Motion Preservation Devices, and Invasive Spinal Bone Stimulators}, Dental Implants {Root Form and Plate Form Dental Implants}, Trauma & Craniomaxillofacial {Screws, Plates, Staples, and Others}, Orthobiologics {Allografts, Bone Graft Substitutes, and Cell-Based Matrices}, and Others] and Biomaterials [Metallic, Ceramics, Polymers, and Natural] - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ALL1181293
  • 210 Pages
  • May 2017
  • Healthcare
Download Sample    Get Discount   
 

Orthopedic implants are medical devices that are used to replace or provide support to damaged bones or joints. These are fabricated using stainless steel and titanium alloys for strength, with plastic coating that acts as an artificial cartilage. These implants are applicable in orthopedic injuries, treatment of several types of arthritis, and fractures. Orthopedic implants also useful in the joint replacement surgery, which is performed to remove the damaged joint and replace it with a new joint, called prosthesis. The remarkable shift from traditional invasive procedures to minimal invasive surgeries has positively impacted the market growth.

Rise in prevalence of orthopedic injuries or diseases and the rapid growth in aging population globally drive the market. In addition, technological innovations in the orthopedic implants industry, acceptance for implantable medical devices, and improvement of healthcare infrastructure in the emerging countries further supplement the market growth. However, high cost associated with procedures involving orthopedic implants treatment and stringent government policies hamper the market growth. Furthermore, the untapped emerging economies present lucrative opportunities for the market. The global orthopedic implants market accounted for $47,261 million in 2016, and is anticipated to reach at $74,796 million by 2023, registering a CAGR of 6.8% from 2017 to 2023.

The global orthopedic implants market is segmented based on product, biomaterial, and geography. Based on product, it is classified into reconstructive joint replacements, spinal implants, dental implants, trauma & craniomaxillofacial, orthobiologics, and others. The reconstructive joint replacements market is further divided into knee, hip, and extremities. Spinal implants are further categorized into spinal fusion devices, non-fusion devices/motion preservation devices, and invasive spinal bone stimulators. Dental implants are further bifurcated into root form dental implants and plate form dental implants. Trauma & Craniomaxillofacial are further categorized into screws, plates, staples, and others. Orthobiologics are further classified into allografts, bone graft substitutes, and cell-based matrices. Based on biomaterial, it is classified into metallic, ceramic, polymeric, and natural biomaterials.

Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the highest market share in the orthopedic implants market in 2016, and is expected to maintain its dominance throughout the forecast period, owing to increase in R&D activities to develop innovative technologies in orthopedic implants. However, Asia-Pacific is expected to emerge as a lucrative area with maximum growth potential, owing to the improvement in healthcare facilities, available disposable income, and rapid development in the economic conditions.

Product development is the key strategy adopted by market players. The report provides a comprehensive analysis of the key players that operate in the global orthopedic implants market.

KEY MARKET BENEFITS

  • The study provides an in-depth analysis of the global orthopedic implants market and the current trends and future estimations to elucidate the imminent investment pockets.
  • The report presents quantitative analysis of the market from 2016 to 2023 to enable stakeholders to capitalize on the prevailing market opportunities.
  • Extensive analysis of the market based on product assists to understand the trends in the industry.
  • Key market players and their strategies are thoroughly analyzed to understand the competitive outlook of the industry.

KEY MARKET SEGMENTS

By Product

  • Reconstructive Joint Replacements

    • Knee Replacement Implants
    • Hip Replacement Implants
    • Extremities

      • Upper Extremity Reconstruction

        • Shoulder Implants
        • Elbow Implants
        • Hand Wrist Implants

      •  Lower Extremity Reconstruction

        • Foot Implants
        • Ankle Implants

  • Spinal Implants

    • Spinal Fusion Devices

      • Thoracolumbar Devices
      • Cervical Fixation Devices
      • Interbody Fusion Devices

    • Non-fusion Devices/Motion Preservation Devices

      • Balloon Kyphoplasty Devices
      • Vertebroplasty Devices

    • Invasive Spinal Bone Stimulators

  • Dental Implants

    • Root Form Dental Implants
    • Plate Form Dental Implants

  • Trauma & Craniomaxillofacial

    • Screws
    • Plates
    • Staples
    • Others

  • Orthobiologics

    • Allografts

By Biomaterial

  • Metallic Biomaterials
  • Polymeric Biomaterials
  • Ceramic Biomaterials
  • Natural Biomaterials

By Geography

  • North America

    • U.S.
    • Canada
    • Mexico

  • Europe

    • Germany
    • France
    • UK
    • Rest of Europe

  • Asia-Pacific

    • Japan
    • China
    • India
    • Rest of Asia-Pacific

  • LAMEA

    • Latin America
    • Middle east
    • Africa

KEY PLAYERS PROFILED

  • Zimmer Biomet Holdings, Inc.
  • Aesculap Implant Systems
  • Medtronic plc.
  • Stryker Corporation
  • Johnson & Johnson (DePuy Synthes)
  • The Orthopedic Implant Company
  • Smith and Nephew plc.
  • Wright Medical Group N.V.
  •  BioTek Instruments, Inc.
  • Conmed Corporation

The other players in the value chain include (profiles not included in the report)

  • Arthrex, Inc.
  • NuVasive, Inc.
  • Globus Medical, Inc.
  • Synthes Holding AG
  • Arthrocare Corporation
  •  Baxter International Inc.
  • Integra Lifesciences Holdings Corporation

CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION

1.2. KEY MARKET BENEFITS

1.3. KEY MARKET SEGMENTS

1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research

1.4.2. Primary research

1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE

3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.2.2. Top winning strategies

3.2.3. Market share analysis, 2016

3.3. PORTERS FIVE FORCES ANALYSIS

3.3.1. Bargaining power of buyers

3.3.2. Bargaining power of suppliers

3.3.3. Threat of substitutes

3.3.4. Threat of new entrants

3.3.5. Competitive rivalry

3.4. CLINICAL TRIALS

3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Rise in incidence of orthopedic diseases coupled with growing ageing population

3.5.1.2. Technological advancements in the field of orthopedic implants

3.5.1.3. Global rise in acceptance of orthopedic implants

3.5.1.4. Improved healthcare facilities in developing countries

3.5.2. Restraints

3.5.2.1. High cost of treatment associated with orthopedic implants procedures

3.5.2.2. Stringent approval process as these are highly specialized devices

3.5.3. Opportunities

3.5.3.1. Huge market opportunities in the developing countries

CHAPTER 4 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. RECONSTRUCTIVE JOINT REPLACEMENTS

4.2.1. Key market trends

4.2.2. Key growth factors and opportunities

4.2.3. Market size and forecast

4.2.4. Knee replacement implants

4.2.4.1. Market size and forecast

4.2.5. Hip replacement implants

4.2.5.1. Market size and forecast

4.2.6. Extremities

4.2.6.1. Market size and forecast

4.2.6.2. Upper Extremity Reconstruction

4.2.6.2.1. Market size and forecast

4.2.6.2.2. Shoulder Reconstruction

4.2.6.2.2.1. Market size and forecast

4.2.6.2.3. Elbow Reconstruction

4.2.6.2.3.1. Market size and forecast

4.2.6.2.4. Hand & Wrist

4.2.6.2.4.1. Market size and forecast

4.2.6.3. Lower Extremity Reconstruction

4.2.6.3.1. Market size and forecast

4.2.6.3.2. Foot Reconstruction

4.2.6.3.2.1. Market size and forecast

4.2.6.3.3. Ankle Reconstruction

4.2.6.3.3.1. Market size and forecast

4.3. SPINAL IMPLANTS

4.3.1. Key market trends

4.3.2. Key growth factors and opportunities

4.3.3. Market size and forecast

4.3.4. Spinal Fusion Devices

4.3.4.1. Market size and forecast

4.3.4.2. Thoracolumbar Devices

4.3.4.2.1. Market size and forecast

4.3.4.3. Cervical Fixation Devices

4.3.4.3.1. Market size and forecast

4.3.4.4. Interbody Fusion Devices

4.3.4.4.1. Market size and forecast

4.3.5. Motion Preservation Devices

4.3.5.1. Market size and forecast

4.3.5.2. Dynamic Stabilization Devices

4.3.5.2.1. Market size and forecast

4.3.5.3. Artificial Discs

4.3.5.3.1. Market size and forecast

4.3.5.4. Annulus Repair Devices

4.3.5.4.1. Market size and forecast

4.3.5.5. Nuclear Disc Prostheses

4.3.5.5.1. Market size and forecast

4.3.6. Vertebral Compression Fracture (VCF) Treatment Devices

4.3.6.1. Market size and forecast

4.3.6.2. Balloon Kyphoplasty Devices

4.3.6.2.1. Market size and forecast

4.3.6.3. Vertebroplasty Devices

4.3.6.3.1. Market size and forecast

4.3.7. Invasive Spinal Bone Stimulators

4.3.7.1. Market size and forecast

4.4. DENTAL IMPLANTS

4.4.1. Key market trends

4.4.2. Key growth factors and opportunities

4.4.3. Market size and forecast

4.4.4. Root Form Dental Implants

4.4.4.1. Market size and forecast

4.4.5. Plate Form Dental Implants

4.4.5.1. Market size and forecast

4.5. ORTHOBIOLOGICS

4.5.1. Key market trends

4.5.2. Key growth factors and opportunities

4.5.3. Market size and forecast

4.5.4. Allografts

4.5.4.1. Market size and forecast

4.5.4.2. Machined Allograft

4.5.4.2.1. Market size and forecast

4.5.4.3. Demineralized Bone Matrix (DBM)

4.5.4.3.1. Market size and forecast

4.5.5. Bone Graft Substitutes

4.5.5.1. Market size and forecast

4.5.5.2. Bone Morphogenic Proteins (BMP)

4.5.5.2.1. Market size and forecast

4.5.5.3. Synthetic Bone Grafts

4.5.5.3.1. Market size and forecast

4.5.6. Cell Based Matrices (CBM)

4.5.6.1. Market size and forecast

4.6. TRAUMA & CRANIOMAXILLOFACIAL

4.6.1. Key market trends

4.6.2. Key growth factors and opportunities

4.6.3. Market size and forecast

4.6.4. Screw

4.6.4.1. Market size and forecast

4.6.5. Plates

4.6.5.1. Market size and forecast

4.6.6. Staples

4.6.6.1. Market size and forecast

4.6.7. Others

4.6.7.1. Market size and forecast

CHAPTER 5 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. CERAMICS BIOMATERIALS

5.2.1. Market size and forecast

5.3. METALLIC BIOMATERIALS

5.3.1. Market size and forecast

5.4. POLYMERIC BIOMATERIALS

5.4.1. Market size and forecast

5.5. NATURAL BIOMATERIALS

5.5.1. Market size and forecast

CHAPTER 6 GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends

6.2.2. Key growth factors and opportunities

6.2.3. Market size and forecast by country

6.2.4. Market size and forecast by Product

6.2.5. Market size and forecast by Biomaterial

6.2.5.1. U.S. market size and forecast

6.2.5.2. Canada market size and forecast

6.2.5.3. Mexico market size and forecast

6.3. EUROPE

6.3.1. Key market trends

6.3.1. Key growth factors and opportunities

6.3.2. Market size and forecast by country

6.3.3. Market size and forecast by Product

6.3.4. Market size and forecast by Biomaterial

6.3.4.1. Germany market size and forecast

6.3.4.2. France market size and forecast

6.3.4.3. UK market size and forecast

6.3.4.4. Rest of Europe market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends

6.4.2. Key growth factors and opportunities

6.4.3. Market size and forecast by country

6.4.4. Market size and forecast by Product

6.4.5. Market size and forecast by Biomaterial

6.4.5.1. Japan market size and forecast

6.4.5.2. China market size and forecast

6.4.5.3. India market size and forecast

6.4.5.4. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends

6.5.2. Key growth factors and opportunities

6.5.3. Market size and forecast by country

6.5.4. Market size and forecast by Product

6.5.5. Market size and forecast by Biomaterial

6.5.5.1. Latin America market size and forecast

6.5.5.2. South Africa market size and forecast

6.5.5.3. Middle East market size and forecast

CHAPTER 7 COMPANY PROFILES

7.1. BIOTEK INSTRUMENTS, INC.

7.1.1. Company overview

7.1.2. Operating business segments

7.1.3. Business performance

7.1.4. Key strategic moves and developments

7.2. CONMED CORPORATION

7.2.1. Company overview

7.2.2. Operating business segments

7.2.3. Business performance

7.2.4. Key strategic moves and developments

7.3. JOHNSON & JOHNSON (DEPUY SYNTHES)

7.3.1. Company overview

7.3.2. Operating business segments

7.3.3. Business performance

7.3.4. Key strategic moves and developments

7.4. MEDTRONIC PLC

7.4.1. Company overview

7.4.2. Operating business segments

7.4.3. Business performance

7.4.4. Key strategic moves and developments

7.5. SMITH AND NEPHEW PLC

7.5.1. Company overview

7.5.2. Operating business segments

7.5.3. Business performance

7.5.4. Key strategic moves and developments

7.6. STRYKER CORPORATION

7.6.1. Company overview

7.6.2. Operating business segments

7.6.3. Business performance

7.6.4. Key strategic moves and developments

7.7. THE ORTHOPAEDIC IMPLANT COMPANY

7.7.1. Company overview

7.7.2. Operating business segments

7.7.3. Business performance

7.7.4. Key strategic moves and developments

7.8. WRIGHT MEDICAL GROUP N.V.

7.8.1. Company overview

7.8.2. Operating business segments

7.8.3. Business performance

7.8.4. Key strategic moves and developments

7.9. ZIMMER BIOMET HOLDINGS, INC.

7.9.1. Company overview

7.9.2. Operating business segments

7.9.3. Business performance

7.9.4. Key strategic moves and developments

7.10. AESCULAP IMPLANT SYSTEMS

7.10.1. Company overview

7.10.2. Operating business segments

7.10.3. Business performance

7.10.4. Key strategic moves and developments

LIST OF TABLES

TABLE 1. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 2. PRODUCTS ALONG WITH THEIR USE IN DIFFERENT INDICATIONS

TABLE 3. GLOBAL RECONSTRUCTIVE JOINT REPLACEMENT MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 4. GLOBAL KNEE REPLACEMENT IMPLANTS MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 5. GLOBAL HIP REPLACEMENT IMPLANTS MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 6. GLOBAL EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 7. GLOBAL UPPER EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 8. GLOBAL SHOULDER RECONSTRUCTION MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 9. GLOBAL ELBOW RECONSTRUCTION MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 10. GLOBAL HAND & WRIST RECONSTRUCTION MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 11. GLOBAL LOWER EXTREMITIES IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 12. GLOBAL FOOT RECONSTRUCTION MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 13. GLOBAL ANKLE RECONSTRUCTION MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 14. PRODUCT ANALYSIS: SPINAL IMPLANTS

TABLE 15. GLOBAL SPINAL IMPALNTS ORTHOPEDIC IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 16. GLOBAL SPINAL FUSION DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 17. GLOBAL THORACOLUMBAR DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 18. GLOBAL CERVICAL FIXATION DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 19. GLOBAL INTERBODY FUSION DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 20. GLOBAL MOTION PRESERVATION DEVICES MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 21. GLOBAL DYNAMIC STABILIZATION DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 22. GLOBAL ARTIFICIAL DISCS MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 23. GLOBAL ANNULUS REPAIR DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 24. GLOBAL NUCLEAR DISC PROSTHESES MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 25. GLOBAL VERTEBRAL COMPRESSION FRACTURE MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 26. GLOBAL BALLOON KYPHOPLASTY DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 27. GLOBAL VERTEBROPLASTY DEVICES MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 28. GLOBAL INVASIVE SPINAL BONE STIMULATORS MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 29. GLOBAL DENTAL IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 30. GLOBAL ROOT-FORM DENTAL IMPLANT MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 31. GLOBAL PLATE-FORM DENTAL IMPLANT MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 32. GLOBAL ORTHOBIOLOGICS IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 33. GLOBAL ALLOGRAFT IMPLANTS MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 34. GLOBAL MACHINED ALLOGRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 35. GLOBAL DEMINERALIZED BONE MATRIX MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 36. GLOBAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 37. GLOBAL BONE MORPHOGENETIC PROTEIN MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 38. GLOBAL SYNTHETIC BONE GRAFTS MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 39. GLOBAL CELL BASED MATRICES MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 40. GLOBAL TRAUMA AND CRANIOMAXILLOFACIAL MARKET, BY TYPE, 2016-2023 ($MILLION)

TABLE 41. DIFFERENT TYPES OF BONE SCREWS AND THEIR APPLICATION

TABLE 42. GLOBAL TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR SCREW, BY REGION, 2016-2023 ($MILLION)

TABLE 43. GLOBAL TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR PLATES, BY REGION, 2016-2023 ($MILLION)

TABLE 44. GLOBAL TRAUMA AND CRANIOMAXILLOFACIAL MARKET FOR STAPLES, BY REGION, 2016-2023 ($MILLION)

TABLE 45. GLOBAL OTHER TRAUMA AND CRANIOMAXILLOFACIAL IMPLANTS MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 46. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)

TABLE 47. GLOBAL CERAMICS BIOMATERIALS MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 48. METALLIC BIOMATERIALS AND THEIR APPLICATIONS

TABLE 49. GLOBAL METALLIC BIOMATERIALS MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 50. GLOBAL POLYMERIC BIOMATERIALS MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 51. GLOBAL NATURAL BIOMATERIALS MARKET, BY REGION, 2016-2023 ($MILLION)

TABLE 52. GLOBAL ORTHOPAEDIC IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023 ($MILLION)

TABLE 53. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 54. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)

TABLE 55. NORTH AMERICA ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)

TABLE 56. RHEUMATOID ARTHRITIS CASES IN U.K. EACH YEAR

TABLE 57. EUROPE ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 58. EUROPE ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)

TABLE 59. EUROPE ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)

TABLE 60. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 61. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)

TABLE 62. ASIA-PACIFIC ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)

TABLE 63. LAMEA ORTHOPEDIC IMPLANT MARKET, BY COUNTRY, 2016-2023 ($MILLION)

TABLE 64. LAMEA ORTHOPEDIC IMPLANT MARKET, BY PRODUCT, 2016-2023 ($MILLION)

TABLE 65. LAMEA ORTHOPEDIC IMPLANT MARKET, BY BIOMATERIAL, 2016-2023 ($MILLION)

TABLE 66. BIOTEK INSTRUMENTS: COMPANY SNAPSHOT

TABLE 67. BIOTEK INSTRUMENTS: OPERATING SEGMENTS

TABLE 68. CONMED: COMPANY SNAPSHOT

TABLE 69. CONMED: OPERATING SEGMENTS

TABLE 70. J&J: COMPANY SNAPSHOT

TABLE 71. J&J: OPERATING SEGMENTS

TABLE 72. MEDTRONIC: COMPANY SNAPSHOT

TABLE 73. MEDTRONIC: OPERATING SEGMENTS

TABLE 74. SMITH AND NEPHEW: COMPANY SNAPSHOT

TABLE 75. SMITH AND NEPHEW: OPERATING SEGMENTS

TABLE 76. STRYKER: COMPANY SNAPSHOT

TABLE 77. STRYKER: OPERATING SEGMENTS

TABLE 78. THE ORTHOPAEDIC IMPLANT: COMPANY SNAPSHOT

TABLE 79. THE ORTHOPAEDIC IMPLANT: OPERATING SEGMENTS

TABLE 80. WRIGHT MEDICAL: COMPANY SNAPSHOT

TABLE 81. WRIGHT MEDICAL: OPERATING SEGMENTS

TABLE 82. ZIMMER: COMPANY SNAPSHOT

TABLE 83. ZIMMER: OPERATING SEGMENTS

TABLE 84. AESCULAP: COMPANY SNAPSHOT

TABLE 85. AESCULAP: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL SNAPSHOT OF ORTHOPEDIC IMPLANTS MARKET, 2016-2023

FIGURE 2. GLOBAL SNAPSHOT OF ORTHOPEDIC IMPLANTS MARKET, BY GEOGRAPHY, 2016-2023

FIGURE 3. GLOBAL ORTHOPEDIC IMPLANTS MARKET SEGMENTATION

FIGURE 4. TOP INVESTMENT POCKETS IN GLOBAL ORTHOPEDIC IMPLANTS MARKET

FIGURE 5. MARKET SHARE ANALYSIS: ORTHOPEDIC IMPLANTS, 2016

FIGURE 6. BARGAINING POWER OF BUYERS, 2016

FIGURE 7. BARGAINING POWER OF SUPPLIERS, 2016

FIGURE 8. THREAT OF SUBSTITUTES, 2016

FIGURE 9. THREAT OF NEW ENTRANTS, 2016

FIGURE 10. COMPETITIVE RIVALRY, 2016

FIGURE 11. CLINICAL TRIALS FOR ORTHOPEDIC IMPLANTS (%)

FIGURE 12. GLOBAL ORTHOPEDIC IMPLANT MARKET: DRIVER & RESTRAINTS

FIGURE 13. GLOBAL ORTHOPEDIC IMPLANTS MARKET, BY TYPE

FIGURE 14. U.S. ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 15. CANADA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 16. MEXICO ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 17. GERMANY ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 18. FRANCE ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 19. UK ORTHOPEDIC IMPLANTS DMARKET, 2016-2023 ($MILLION)

FIGURE 20. REST OF EUROPE ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 21. JAPAN ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 22. CHINA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 23. INDIA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 24. REST OF ASIA-PACIFIC ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 25. LATIN AMERICA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 26. SOUTH AFRICA ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 27. MIDDLE EAST ORTHOPEDIC IMPLANTS MARKET, 2016-2023 ($MILLION)

FIGURE 28. BIOTEK INSTRUMENTS: REVENUE, 2014-2016 ($MILLION)

FIGURE 29. BIOTEK INSTRUMENTS: REVENUE BY SEGMENT, 2016 (%)

FIGURE 30. BIOTEK INSTRUMENTS: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 31. CONMED: REVENUE, 2014-2016 ($MILLION)

FIGURE 32. CONMED: REVENUE BY SEGMENT, 2016 (%)

FIGURE 33. CONMED: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 34. J&J: REVENUE, 2014-2016 ($MILLION)

FIGURE 35. J&J: REVENUE BY SEGMENT, 2016 (%)

FIGURE 36. J&J: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 37. MEDTRONIC: REVENUE, 2014-2016 ($MILLION)

FIGURE 38. MEDTRONIC: REVENUE BY SEGMENT, 2016 (%)

FIGURE 39. MEDTRONIC: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 40. SMITH AND NEPHEW: REVENUE, 2014-2016 ($MILLION)

FIGURE 41. SMITH AND NEPHEW: REVENUE BY SEGMENT, 2016 (%)

FIGURE 42. SMITH AND NEPHEW: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 43. STRYKER: REVENUE, 2014-2016 ($MILLION)

FIGURE 44. STRYKER: REVENUE BY SEGMENT, 2016 (%)

FIGURE 45. STRYKER: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 46. THE ORTHOPAEDIC IMPLANT: REVENUE, 2014-2016 ($MILLION)

FIGURE 47. THE ORTHOPAEDIC IMPLANT: REVENUE BY SEGMENT, 2016 (%)

FIGURE 48. THE ORTHOPAEDIC IMPLANT: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 49. WRIGHT MEDICAL: REVENUE, 2014-2016 ($MILLION)

FIGURE 50. WRIGHT MEDICAL: REVENUE BY SEGMENT, 2016 (%)

FIGURE 51. WRIGHT MEDICAL: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 52. ZIMMER: REVENUE, 2014-2016 ($MILLION)

FIGURE 53. ZIMMER: REVENUE BY SEGMENT, 2016 (%)

FIGURE 54. ZIMMER: REVENUE BY GEOGRAPHY, 2016 (%)

FIGURE 55. AESCULAP: REVENUE, 2014-2016 ($MILLION)

FIGURE 56. AESCULAP: REVENUE BY SEGMENT, 2016 (%)

FIGURE 57. AESCULAP: REVENUE BY GEOGRAPHY, 2016 (%)

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Regenerative Medicine Market by Product Type (Cell Therapy, Gene Therapy, Tissue Engineering, and Small Molecule & Biologic), Material (Synthetic Material, Biologically Derived Material, Genetically Engineered Material, and Pharmaceutical), and Application (Cardiovascular, Oncology, Dermatology, Musculoskeletal, Wound Healing, Ophthalmology, Neurology, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

The global regenerative medicine market was valued at $5,444 million in 2016, and is estimated to reach $39,325 million by 2023, registering a CAGR of 32.2% from 2017 to 2023. Regenerative medicines are used to repair, replace, and regenerate tissues & organs that are affected owin...

  • Publish Date: May 29, 2018
  • $5370
World Medical Robotics and Computer - Assisted Surgery Market - Opportunities and Forecasts, 2015 - 2022

The medical robotics and computer-assisted surgery is a combination of equipment, accessories, software, and services that aid in performing different functions, such as robotic minimally invasive and non-invasive radiosurgeries, rehabilitation therapies, and hospital & pharmacy automation. Surgical robotics...

  • Publish Date: May 1, 2016
  • $5370